Effect of the GLP-1 Receptor Agonist Exenatide on Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Phase of Trial: Phase II/III
Latest Information Update: 17 Apr 2018
At a glance
- Drugs Exenatide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 21 Mar 2018 Status changed from recruiting to completed.
- 29 May 2017 Status changed from not yet recruiting to recruiting.
- 14 Apr 2016 New trial record